Clinical trial
S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile…
NCT00058448 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00058448 |
|---|---|
| Title | S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) |
| Official title | Phase II Study Of Weekly Docetaxel In Patients With Advanced Epidermoid Carcinoma Of The Penis |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Penile Cancer |
| Intervention type | Drug |
| Interventions | docetaxel |
| Enrollment | 1 |
| Start date | Oct 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Apr 9, 2003 |
| Last update posted | Jun 28, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: